Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis. - Wikidata - awgldk - TriplyDB

Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis.

Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis.

http://www.wikidata.org/entity/Q33755139

about

Neoadjuvant therapy for gastroesophageal adenocarcinoma Neo-adjuvant chemo(radio)therapy in gastric cancer: Current status and future perspectives Neoadjuvant or adjuvant therapy for gastric cancer Neoadjuvant chemotherapy followed by surgery versus surgery alone for gastric carcinoma: systematic review and meta-analysis of randomized controlled trials Decreased intratumoral Foxp3 Tregs and increased dendritic cell density by neoadjuvant chemotherapy associated with favorable prognosis in advanced gastric cancer Comparison between better and poorly differentiated locally advanced gastric cancer in preoperative chemotherapy: a retrospective, comparative study at a single tertiary care institute Surgery combined with intraoperative hyperthermic intraperitoneal chemotherapy (IHIC) for gastric cancer: a systematic review and meta-analysis of randomised controlled trials.An updated meta-analysis of randomized controlled trial assessing the effect of neoadjuvant chemotherapy in advanced gastric cancer.Perioperative chemotherapy more of a benefit for overall survival than adjuvant chemotherapy for operable gastric cancer: an updated Meta-analysis.Correlation between apparent diffusion coefficients and HER2 status in gastric cancers: pilot study.Which is better for gastric cancer patients, perioperative or adjuvant chemotherapy: a meta-analysis.Adjuvant chemoradiotherapy after d2-lymphadenectomy for gastric cancer: the role of n-ratio in patient selection. results of a single cancer center.Effectiveness of 5-flurouracil-based neoadjuvant chemotherapy in locally-advanced gastric/gastroesophageal cancer: a meta-analysis.Thioredoxin interacting protein and its association with clinical outcome in gastro-oesophageal adenocarcinoma A phase II study of a modified FOLFOX6 regimen as neoadjuvant chemotherapy for locally advanced gastric cancer.The relationship between Lin28 and the chemotherapy response of gastric cancer The postoperative component of MAGIC chemotherapy is associated with improved prognosis following surgical resection in gastric and gastrooesophageal junction adenocarcinomas Docetaxel, Cisplatin, and 5-Fluorouracil as perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma.Impact of neoadjuvant chemotherapy with PELF-protocoll versus surgery alone in the treatment of advanced gastric carcinoma.Management of advanced gastric cancer: An overview of major findings from meta-analysis.Quality of care indicators for the surgical treatment of gastric cancer: a systematic review.Neoadjuvant chemotherapy for nonmetastatic esophago-gastric adenocarcinomas: a systematic review and meta-analysis.Perioperative chemotherapy in locally advanced gastric cancer.Role of imaging in predicting response to neoadjuvant chemotherapy in gastric cancer.Adjuvant and neoadjuvant options in resectable gastric cancer: is there an optimal treatment approach?Capecitabine plus paclitaxel induction treatment in gastric cancer patients with liver metastasis: a prospective, uncontrolled, open-label Phase II clinical study.Neoadjuvant chemotherapy for gastric cancer: a meta-analysis of randomized, controlled trials.Perioperative chemotherapy for resectable gastric cancer - what is the evidence?Predicting Residual Disease in Incidental Gallbladder Cancer: Risk Stratification for Modified Treatment Strategies.Increasing survival gap between young and elderly gastric cancer patients.Systemic Chemotherapy Combined with Resection for Locally Advanced Gallbladder Carcinoma: Surgical and Survival Outcomes.Neoadjuvant chemotherapy in controlling lymph node metastasis for locally advanced gastric cancer in a Chinese population.Role of intravoxel incoherent motion MR imaging in preoperative assessing HER2 status of gastric cancers.A study on comparison of overall survival and disease- free survival among gastric cancer patients treated with two adjuvant and neoadjuvant methods.Gastric cancer: clinical aspects, epidemiology and molecular background.Neoadjuvant plus adjuvant chemotherapy benefits overall survival of locally advanced gastric cancer.Surgical indications for gastrectomy combined with distal or partial pancreatectomy in patients with gastric cancer.The newly proposed clinical and post-neoadjuvant treatment staging classifications for gastric adenocarcinoma for the American Joint Committee on Cancer (AJCC) staging.An application study of low-dose computed tomography perfusion imaging for evaluation of the efficacy of neoadjuvant chemotherapy for advanced gastric adenocarcinoma.Effect of neoadjuvant chemotherapy in patients with gastric cancer: a PRISMA-compliant systematic review and meta-analysis.

P2860

Q26746147-43F99888-9E8B-4653-9E08-27F38C294772 Q26774283-95A9E9D6-5CB6-406A-B51A-289C1F79FDFE Q26797427-AB77D085-2270-4389-835F-50A19A959F20 Q31150068-EE12046A-F59B-466C-B435-72500163FBFF Q34121330-C286C56F-37D5-4F52-B5E9-FD6E00FD8BEF Q34254234-324E4D4A-CC95-49E4-9475-0CD21DCE4EBF Q34590558-3C410D50-04D4-40D3-8390-6208B594A25D Q35163577-8FEE1F97-A154-4758-AFBC-FB2A157193C4 Q35737764-DF05E0F7-AEBF-4672-887E-CBF441F854A8 Q35815603-D78B9C39-DA9D-499A-A1D1-2BE77F87CAEE Q36103180-F7B0EE5A-C710-4B72-8333-194764E231AF Q36524081-187FB9CD-B268-483A-80F4-4F02AFDE1664 Q36529266-469FC9F9-3BA6-4D22-B5BA-98581D4BF46F Q37133536-15936EA4-138A-4B0A-A5F3-E510BDA0C956 Q37174037-6E719A0A-C93F-47FD-B90D-B5E6FC41FF82 Q37213326-5C61D729-3C57-43E4-9F33-E1842E838455 Q37217887-4A1D9417-EE35-458D-9DD1-63617CB5AC36 Q37429923-1F717FDE-04F6-4E20-9B83-DDCC52BDD9ED Q37541524-E2EDFE58-C5F5-44E7-9896-1430AE99ED36 Q37718510-F875FB38-E077-45A6-A6F2-7AD9E8489BD2 Q38051100-CA4C949A-AD25-4AE5-AD1E-3C65E3E90E3A Q38113822-1B781E87-CE41-424C-B850-328834501725 Q38169894-68DEB3F7-5F4C-4E92-81BE-889166FFC575 Q38192620-DC0F23C0-2F6D-46A4-BFEA-C5E1B715B761 Q38364619-0A0E2933-4636-4BDC-B9EC-B790D2CE50AA Q38391749-CCF08B9A-B848-45D1-97EF-9B3E054B39D5 Q38410192-D278E742-3B2C-41FB-930C-FF926A2C2889 Q38748376-F3D69201-8B8A-41FA-AC4A-553AE1B15207 Q38796651-D1154CF8-C047-47DD-9B35-B9E127A22381 Q40300882-78D74B6B-DB8D-4F96-BB85-D6463DB4FBE1 Q40327923-1AA1B606-2EB5-42F8-B12F-876C726C1FE8 Q40936092-298DD46F-76AB-4EC7-99A2-49837066653A Q41472425-485F4A8A-A55B-4C15-9549-7AE64FB2E341 Q41571695-C7C25CE4-8F37-4171-A715-62FB9B38B483 Q42615450-077D1101-555B-4BDF-A385-617FBF7A0809 Q42971706-96A736A4-2F10-4615-93B8-BB1362B5CBA4 Q44228036-6A003BC8-513B-4BAD-934A-98BA84F04B0A Q47922009-82B9EA51-77F0-4D0A-9A79-403E01DDD879 Q48127059-17110496-2A8E-4A0C-8958-D8E51EFFD357 Q49548232-1DB9B16E-2630-4B89-823D-67F4E27AB6D0

P2860

Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis.

http://www.wikidata.org/entity/Q33755139

description

2010 nî lūn-bûn

@nan

2010 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年論文

@yue

2010年論文

@zh-hant

2010年論文

@zh-hk

2010年論文

@zh-mo

2010年論文

@zh-tw

2010年论文

@wuu

name

Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis.

@ast

Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis.

@en

type

label

Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis.

@ast

Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis.

@en

prefLabel

Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis.

@ast

Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis.

@en

P1433

Q33755139-987E179E-2A6F-4572-B6E0-C46891701B9A

P1476

Q33755139-FAB3E110-C62E-429C-B9EF-B8515A474BF4

P2093

Q33755139-30B75314-258E-477C-A2A5-8367D1A219E5

Q33755139-42B00901-A507-41DB-9874-C2DADB701FA6

Q33755139-ACDC2528-96F0-4FC5-86DF-184AF17BF8FB

Q33755139-B1BA422A-376B-4EDA-9884-AAAFB48A2B0C

P2860

Q33755139-04A37712-7B39-4629-839E-404CA2C5561B

Q33755139-0ABD11D0-6B41-4A8E-9F8C-F8559B4D5C44

Q33755139-0C70AD78-6408-438C-8950-57E1D91C5F89

Q33755139-2B1DDB71-D708-47A9-9B6E-AF028270D829

Q33755139-36D807A4-01D2-4168-8FB5-0B8467F50239

Q33755139-3732AFE7-A8F3-409D-A17A-E1B6534CF290

Q33755139-634FFE82-BE98-4FC1-B229-C7F8FA6EA0AA

Q33755139-64DA29B9-A5C8-4A24-AFEA-CE5EB0883AF6

Q33755139-6E6E2A36-9EE0-4986-A6F1-DB5C1EA8F432

Q33755139-7A8C9336-4CBE-4346-A3F4-EEF93E65F658

P304

Q33755139-E4338CC4-1E65-4CA6-AD1B-20A94AA7D75E

P31

Q33755139-F620A50E-4C0F-4290-933B-C2BE6164496A

Q33755139-c81f1da2-8e7b-4a3c-8193-9e0fa5982e77

P356

Q33755139-321EB80B-5DA4-4621-9300-F7BC5F78BF9B

P407

Q33755139-5B9D6CE6-F20D-46CD-BA45-6CE9EE812245

P433

Q33755139-B12A5901-DD1B-487F-93A6-AB14BE5804B9

P478

Q33755139-DC2167C6-F357-41C5-B5E7-7A47AC9B8CD4

P577

Q33755139-A5FEB59F-1C22-40E9-9291-C419DF750A88

P5875

Q33755139-B99CDD4C-AD40-4487-B288-3827D23E0F11

P698

Q33755139-05C95B11-A9FD-4CFD-AE96-81B1DB95F427

P921

Q33755139-8061BBD9-B57C-45E3-8B38-B97874F85473

P932

Q33755139-2F37637D-8347-4096-9AF0-FF75B405DF55

P356

WJG.V16.I44.5621

P1433

World Journal of Gastroenterology

P1476

Neoadjuvant chemotherapy for advanced gastric cancer: a meta-analysis.

@en

P2093

Jing Qin

http://www.w3.org/2001/XMLSchema#string

Tian-Shu Liu

http://www.w3.org/2001/XMLSchema#string

Wei Li

http://www.w3.org/2001/XMLSchema#string

Yi-Hong Sun

http://www.w3.org/2001/XMLSchema#string

P2860

Assessing the quality of reports of randomized clinical trials: is blinding necessary?

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

Patterns of cancer incidence, mortality, and prevalence across five continents: defining priorities to reduce cancer disparities in different geographic regions of the world

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

Capecitabine and oxaliplatin for advanced esophagogastric cancer.

A pilot study of combination chemotherapy with S-1 and low-dose cisplatin for highly advanced gastric cancer.

Preoperative chemotherapy in locally advanced and nonresectable gastric cancer: a phase II study with etoposide, doxorubicin, and cisplatin.

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

A meta-analysis of randomized controlled trials that compared neoadjuvant chemotherapy and surgery to surgery alone for resectable esophageal cancer.

P304

5621-5628

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3748/WJG.V16.I44.5621

http://www.w3.org/2001/XMLSchema#string

P407

P433

44

http://www.w3.org/2001/XMLSchema#string

P478

16

http://www.w3.org/2001/XMLSchema#string

P577

2010-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272670530

http://www.w3.org/2001/XMLSchema#string

P698

21105197

http://www.w3.org/2001/XMLSchema#string

P921

P932

2992682

http://www.w3.org/2001/XMLSchema#string